MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM
Medtronic, Inc. · Decision date Jul 31, 1997
What did the FDA approve?
The FDA approved Medtronic's Activa Tremor Control System on July 31, 1997, under PMA P960009. The approval covers the Model 3387 DBS lead, Model 7495 extension, Model 7424 implantable pulse generator, Model 7458 memory module, Model 7432 console programmer, bur hole ring and cap, Model 7452 magnet, Model 3625 test stimulator, and Model 3353/3354 lead frame kits and accessories.
The dated approval statement describes the device as indicated for unilateral thalamic stimulation to suppress upper extremity tremor in patients diagnosed with essential tremor or parkinsonian tremor not adequately controlled by medications, where the tremor constitutes a significant functional disability. The statement reports an intended use; it does not independently establish safety or clinical effectiveness.
FDA approval order statement
APPROVAL FOR THE MEDTRONIC(R) ACTIVA(TM) TREMOR CONTROL SYSTEM WHICH INCLUDES THE MODEL 3387 DBS(TM) LEAD, MODEL 7495 EXTENSION, MODEL 7424 IMPLANTABLE PULSE GENERATOR (IPG), MODEL 7458 MEMORY MODULE, MODEL 7432 CONSOLE PROGRAMMER, BUR HOLE RING AND CAP, MODEL 7452 MAGNET, MODEL 3625 TEST STIMULATOR (SCREENER) AND MODEL 3353/3354 LEAD FRAME KITS AND ACCESSORIES. THIS DEVIC IS INDICATED FOR UNILATERAL THALAMIC STIMULATION FOR THE SUPPRESSION OF TREMOR IN THE UPPER EXTREMITY IN PATIENTS WHO ARE DIAGNOSED WITH ESSENTIAL TREMOR OR PARKINSONIAN TREMOR NOT ADEQUATELY CONTROLLED BY MEDICATIONS AND WHERE THE TREMOR CONSTITUTES A SIGNIFICANT FUNCTIONAL DISABILITY.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Neurology
- Decision date
- Jul 31, 1997
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P960009
- Regulatory pathway
- Premarket approval application
- Applicant
- Medtronic, Inc.
- Product code
- MHY
- Decision code
- APPR
- Decision date
- Jul 31, 1997
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.
- Applicant
- Medtronic, Inc.
- Product code
- MHY
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P960009 received
Application receipt date recorded by FDA.
P960009 · FDA decision
APPR
P960009/S546 · Related supplement
MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM
P960009/S542 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S547 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (DBS Neurostimulator Implantable B35200)
P960009/S548 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S545 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (B32000)
Timeline entries are records held by MedtechLedger for P960009. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P960009
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MEDTRONIC ACTIVA TREMOR CONTROL SYSTEMP960009/S546 | Medtronic, Inc. | PMA supplement | Sep 24, 2026 | FDA |
| Medtronic, Inc. | PMA supplement | Oct 6, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 29, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 30, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Nov 8, 2026 | FDA |
Explore the linked device profile
Other records with product code MHY
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
Deep Brain Stimulation (DBS) EPGP140009/S141 | ABBOTT MEDICAL | PMA supplement | Oct 28, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Oct 27, 2026 | FDA | |
Infinity DBS IPGP140009/S139 | ABBOTT MEDICAL | PMA supplement | Sep 23, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 7000 Central Ave., NE, Minneapolis, MN, 55432
Sources and methodology
- Original FDA record: P960009
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
